Periventricular leukomalacia
Periventricular leukomalacia (PVL) is a form of white matter brain injury, characterized by the softening of the white matter near the ventricles. These ventricles are filled with fluid and are located in the center of the brain. The condition often affects premature infants, leading to long-term developmental delays and motor disorders.
Causes[edit | edit source]
The exact cause of PVL is unknown, but it is believed to be due to a lack of oxygen or blood flow to the periventricular area of the brain, which results in the death of brain tissue. This lack of oxygen or blood flow can occur before, during, or after birth. Factors that may contribute to the development of PVL include infection, inflammation, and premature birth.
Symptoms[edit | edit source]
The symptoms of PVL vary depending on the severity of the injury and the specific areas of the brain that are affected. Common symptoms include motor disorders, developmental delays, and cognitive impairments. In severe cases, children with PVL may have cerebral palsy, epilepsy, or learning disabilities.
Diagnosis[edit | edit source]
PVL is typically diagnosed through magnetic resonance imaging (MRI) or ultrasound of the brain. These imaging tests can reveal the characteristic softening and cystic degeneration of the white matter near the ventricles.
Treatment[edit | edit source]
There is currently no cure for PVL. Treatment is focused on managing symptoms and promoting the child's development and quality of life. This may include physical therapy, occupational therapy, speech therapy, and special education services.
Prognosis[edit | edit source]
The prognosis for children with PVL depends on the severity of the injury and the specific areas of the brain that are affected. Some children may have mild symptoms and relatively normal development, while others may have severe disabilities.
See also[edit | edit source]
Periventricular leukomalacia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD